Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, T-Cell | 7 | 2025 | 308 | 2.470 |
Why?
|
Lymphoma, T-Cell, Peripheral | 5 | 2023 | 125 | 2.370 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 3 | 2017 | 210 | 1.230 |
Why?
|
Receptors, Immunologic | 2 | 2024 | 1418 | 1.010 |
Why?
|
Mucin-1 | 4 | 2017 | 536 | 0.960 |
Why?
|
Lymphoma, AIDS-Related | 1 | 2022 | 79 | 0.760 |
Why?
|
Lectins, C-Type | 1 | 2024 | 591 | 0.720 |
Why?
|
Azacitidine | 3 | 2023 | 336 | 0.690 |
Why?
|
Nuclear Physics | 6 | 2014 | 73 | 0.650 |
Why?
|
Depsipeptides | 3 | 2024 | 95 | 0.540 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2024 | 3608 | 0.540 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 920 | 0.540 |
Why?
|
Receptors, IgG | 1 | 2019 | 563 | 0.520 |
Why?
|
Hodgkin Disease | 1 | 2022 | 1383 | 0.450 |
Why?
|
Elementary Particles | 4 | 2014 | 50 | 0.440 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2022 | 2204 | 0.420 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1433 | 0.390 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 11872 | 0.360 |
Why?
|
Aminopterin | 2 | 2024 | 15 | 0.360 |
Why?
|
Oxidative Stress | 2 | 2017 | 3139 | 0.310 |
Why?
|
Models, Theoretical | 6 | 2014 | 3561 | 0.280 |
Why?
|
Cell Line, Tumor | 8 | 2024 | 17097 | 0.250 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2025 | 53 | 0.230 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9410 | 0.220 |
Why?
|
Elementary Particle Interactions | 2 | 2013 | 17 | 0.220 |
Why?
|
Peptides | 1 | 2015 | 4348 | 0.210 |
Why?
|
Cell Proliferation | 2 | 2017 | 10455 | 0.210 |
Why?
|
Apoptosis | 2 | 2017 | 9513 | 0.210 |
Why?
|
Registries | 1 | 2019 | 8351 | 0.200 |
Why?
|
Ifosfamide | 1 | 2022 | 233 | 0.200 |
Why?
|
Cancer Vaccines | 3 | 2019 | 1041 | 0.190 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2024 | 231 | 0.190 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5859 | 0.180 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2824 | 0.180 |
Why?
|
Ikaros Transcription Factor | 1 | 2022 | 233 | 0.180 |
Why?
|
Lymphoma, Follicular | 1 | 2024 | 460 | 0.170 |
Why?
|
Exanthema | 1 | 2024 | 502 | 0.160 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2024 | 777 | 0.160 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2022 | 678 | 0.150 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2144 | 0.150 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18330 | 0.150 |
Why?
|
Oncogenes | 1 | 2023 | 1232 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2019 | 3626 | 0.140 |
Why?
|
Mice | 8 | 2024 | 81912 | 0.140 |
Why?
|
Mesons | 2 | 2014 | 28 | 0.140 |
Why?
|
Multiple Myeloma | 3 | 2022 | 5186 | 0.140 |
Why?
|
Lymphoma, B-Cell | 1 | 2023 | 945 | 0.140 |
Why?
|
Receptors, Fc | 1 | 2019 | 537 | 0.130 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2209 | 0.120 |
Why?
|
Cell Nucleus | 1 | 2023 | 2875 | 0.120 |
Why?
|
Flow Cytometry | 2 | 2015 | 5891 | 0.120 |
Why?
|
NADP | 1 | 2015 | 229 | 0.110 |
Why?
|
Neutrons | 1 | 2014 | 78 | 0.110 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10254 | 0.110 |
Why?
|
Luminescent Measurements | 1 | 2015 | 342 | 0.110 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 414 | 0.110 |
Why?
|
Cell Communication | 2 | 2017 | 1660 | 0.100 |
Why?
|
Animals | 9 | 2024 | 168965 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2022 | 1592 | 0.100 |
Why?
|
Humans | 23 | 2025 | 767040 | 0.100 |
Why?
|
Antigens, Neoplasm | 2 | 2017 | 1997 | 0.100 |
Why?
|
Glutathione | 1 | 2015 | 589 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1900 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1697 | 0.100 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13650 | 0.090 |
Why?
|
Stromal Cells | 1 | 2017 | 1335 | 0.090 |
Why?
|
Autoimmune Diseases | 1 | 2023 | 2255 | 0.090 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2221 | 0.090 |
Why?
|
Necrosis | 1 | 2015 | 1614 | 0.090 |
Why?
|
Remission Induction | 1 | 2016 | 2408 | 0.090 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1837 | 0.090 |
Why?
|
Drug Synergism | 1 | 2015 | 1759 | 0.090 |
Why?
|
Skin | 1 | 2024 | 4499 | 0.090 |
Why?
|
Mice, SCID | 1 | 2015 | 2626 | 0.080 |
Why?
|
Dendritic Cells | 2 | 2019 | 2745 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1150 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2022 | 5332 | 0.080 |
Why?
|
Coculture Techniques | 3 | 2017 | 1337 | 0.080 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3944 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6844 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4572 | 0.070 |
Why?
|
Blotting, Western | 1 | 2015 | 5022 | 0.070 |
Why?
|
Immunotherapy, Adoptive | 1 | 2017 | 1502 | 0.070 |
Why?
|
Protons | 1 | 2013 | 1101 | 0.070 |
Why?
|
Tumor Cells, Cultured | 1 | 2015 | 6106 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2019 | 4648 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 9245 | 0.070 |
Why?
|
Transfection | 1 | 2015 | 5753 | 0.070 |
Why?
|
Bone Marrow | 1 | 2017 | 2926 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7469 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2018 | 3049 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4210 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2887 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2025 | 65295 | 0.060 |
Why?
|
Aged | 6 | 2025 | 171319 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12823 | 0.060 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 2024 | 40 | 0.060 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2024 | 32 | 0.060 |
Why?
|
Vaccination | 1 | 2016 | 3434 | 0.060 |
Why?
|
Prognosis | 1 | 2025 | 29963 | 0.060 |
Why?
|
Folic Acid Antagonists | 1 | 2024 | 74 | 0.060 |
Why?
|
Exudates and Transudates | 1 | 2024 | 175 | 0.060 |
Why?
|
Acetyl Coenzyme A | 1 | 2023 | 74 | 0.050 |
Why?
|
Co-Repressor Proteins | 1 | 2023 | 190 | 0.050 |
Why?
|
Perineum | 1 | 2024 | 212 | 0.050 |
Why?
|
Doxycycline | 1 | 2024 | 348 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2023 | 321 | 0.050 |
Why?
|
Middle Aged | 5 | 2025 | 223233 | 0.050 |
Why?
|
Adult | 5 | 2025 | 223317 | 0.050 |
Why?
|
Anal Canal | 1 | 2024 | 375 | 0.050 |
Why?
|
Female | 7 | 2025 | 396660 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8628 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2015 | 12793 | 0.040 |
Why?
|
Young Adult | 2 | 2025 | 59980 | 0.040 |
Why?
|
Glycolysis | 1 | 2023 | 836 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2023 | 1058 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2025 | 81659 | 0.040 |
Why?
|
Abdomen | 1 | 2024 | 1138 | 0.040 |
Why?
|
Male | 5 | 2025 | 364203 | 0.040 |
Why?
|
Cross-Priming | 1 | 2017 | 75 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39317 | 0.040 |
Why?
|
Perforin | 1 | 2017 | 167 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1751 | 0.040 |
Why?
|
Ubiquitination | 1 | 2022 | 1008 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2015 | 22254 | 0.040 |
Why?
|
Virus Activation | 1 | 2019 | 322 | 0.030 |
Why?
|
Thalidomide | 1 | 2022 | 886 | 0.030 |
Why?
|
Retroviridae | 1 | 2019 | 846 | 0.030 |
Why?
|
Adolescent | 1 | 2025 | 89046 | 0.030 |
Why?
|
Signal Transduction | 2 | 2017 | 23621 | 0.030 |
Why?
|
Isoantigens | 1 | 2017 | 562 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2019 | 2012 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2017 | 1352 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 561 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2023 | 2800 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1566 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1560 | 0.030 |
Why?
|
Electrons | 1 | 2014 | 264 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 872 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 581 | 0.030 |
Why?
|
Biopsy | 1 | 2024 | 6777 | 0.020 |
Why?
|
Down-Regulation | 1 | 2019 | 2931 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 1012 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 998 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 799 | 0.020 |
Why?
|
Gene Silencing | 1 | 2017 | 1505 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1854 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4838 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2017 | 3154 | 0.020 |
Why?
|
Pain | 1 | 2024 | 5101 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 12986 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2163 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5499 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15851 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4426 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7587 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12158 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2016 | 3114 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9362 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26325 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7446 | 0.010 |
Why?
|
MicroRNAs | 1 | 2017 | 3792 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20741 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22361 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11657 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5716 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59548 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 41718 | 0.010 |
Why?
|
Concepts
(168)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(60)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_